|Year : 2014 | Volume
| Issue : 4 | Page : 21-25
Ki-67 and p53 expression in solitary sporadic, syndrome associated and recurrent keratocystic odontogenic tumor
Jyoti Alur1, TV Narayan2, Leeky Mohanty1, Sadhana Shenoy1, Saleha Jamadar1, Shobith Shetty1
1 Department of Oral Pathology and Microbiology, The Oxford Dental College, Hospital and Research Centre, Karnataka, India
2 Impression Dental Care, No 102, Elegant Desire, Coles Road, Frazer Town, Bangalore, Karnataka, India
|Date of Submission||28-Oct-2013|
|Date of Acceptance||12-Jun-2014|
|Date of Web Publication||20-Sep-2014|
No 281,5th Main, 15th 'A' Cross, Sector 6 HSR Layout, Bangalore - 560102 Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Ki-67 and p53 are markers expressed in actively proliferating cells, particularly in neoplasms. Objectives: (1) To study the proliferative potential of epithelia in Solitary Sporadic, Syndrome-associated and Recurrent Keratocystic odontogenic tumors (KCOTs) using Ki67 and p53 labeling indices (LI). (2) To derive a relationship if any between the expression of these proteins and the biologic behavior of Solitary Sporadic and Syndrome associated KCOTs. Study Design: Thirteen paraffin embedded blocks of KCOTs (Solitary Sporadic, n = 03; Recurrent, n = 03; Syndrome associated, n = 07) were stained immunohistochemically for Ki-67 and p53 and labeling indices were calculated. Statistical Analysis: Z test with predetermined alpha set at 0.05 was used for the comparison of Ki-67 positivity between the three groups and p53 positivity between the three groups. Results: Ki-67 labeling indices were: 30% in solitary sporadic; 26% in recurrent; and 32% in syndrome associated KCOTs. p53 labeling indices were: 19% in solitary sporadic; 23% in recurrent; and 21% in syndrome-associated KCOTs. There was no difference seen in the rate of proliferation in the epithelial linings between the three groups. However, in our cases where Ki-67 positivity was seen there was expression of p53. Though not statistically significant a trend was seen, reflecting the loss of balance between the proliferative potential and apoptotic activity. Conclusion: On the basis of proliferative index alone it is not possible to comment on biological behavior of KCOTs associated with syndrome versus those of solitary and recurrent. There is probably a mesenchymal role which needs to be researched.
Keywords: Ki-67, keratocystic odontogenic tumor, nevoid basal cell carcinoma syndrome, p53
|How to cite this article:|
Alur J, Narayan T V, Mohanty L, Shenoy S, Jamadar S, Shetty S. Ki-67 and p53 expression in solitary sporadic, syndrome associated and recurrent keratocystic odontogenic tumor. J Oral Maxillofac Pathol 2014;18, Suppl S1:21-5
|How to cite this URL:|
Alur J, Narayan T V, Mohanty L, Shenoy S, Jamadar S, Shetty S. Ki-67 and p53 expression in solitary sporadic, syndrome associated and recurrent keratocystic odontogenic tumor. J Oral Maxillofac Pathol [serial online] 2014 [cited 2021 Jul 28];18, Suppl S1:21-5. Available from: https://www.jomfp.in/text.asp?2014/18/4/21/141330
| Introduction|| |
Odontogenic keratocyst (OKC) is one of the most aggressive odontogenic cysts. In the recent World Health Organization classification of Head and Neck Tumors, keratocyst has been reclassified as a benign neoplasm, designated as "Keratocystic Odontogenic tumor" (KCOT).  KCOTs can arise sporadically and about 4-5% of KCOTs arise in association with nevoid basal cell carcinoma syndrome (NBCCS).  The aggressive biological behavior of the KCOTs and its tendency to recur might be associated with cell kinetics in the lining epithelium.
Several studies have been done comparing solitary, recurrent and syndrome-associated KCOTs. The proliferative activity of the epithelial lining of KCOTs has been the focus of numerous investigations. Studies have shown conflicting results with few of them showing the expression of cell-cycle-related proteins in the lining epithelium to be different in sporadic KCOTs as compared with KCOTs associated with the NBCCS. The different biological behavior of the latter group was suggested to be due to the underlying genetic abnormalities. ,, The aim of the present study was to compare the expression pattern of Ki-67 and p53 in the epithelial lining of Solitary Sporadic, Recurrent KCOTs and KCOTs-associated with NBCCS and to derive a relationship if any between the expression of these proteins and the biological behavior of Solitary Sporadic and Syndrome-associated KCOTs.
| Materials and methods|| |
A total of 13 formalin fixed, paraffin embedded tissue blocks were retrieved from the archives of our department, which included three cases of Solitary Sporadic KCOTs, 3 Recurrent KCOTs and seven Syndrome-associated KCOTs.
Sections of 4 μm were taken from the paraffin embedded blocks and mounted on Polysilane-coated slides. The slides were incubated at 60 o C overnight. The sections were deparaffinized in two changes of xylene for 5 min each and then the slides were hydrated and cleared through different grades of alcohol. The tissues were then incubated with 3% H2O2 in methanol for 20 min to block the endogenous peroxidase activity. Then the slides were washed in Tris Buffer solution (TBS) for 5 min and subjected to antigen retrieval. The slides were heated in microwave oven with 0.1 m Ethylene diamine tetra acetic acid (PH 8.0) at 800 w for 12 min and 200 w for 15 min for antigen retrieval. The buffer was then cooled back to room temperature and the sections were subjected to two washes of TBS. The sections were incubated for 5 min with protein block to eliminate background staining. The sections were then incubated with primary antibody: Anti Ki-67 monoclonal mouse antibody (Biogenex (BGX), Clone BGX-297) and anti p53 monoclonal mouse antibody (Dako (DO), Clone DO-7) for 45 min. Lymphoma sections were used as positive control for both Ki-67 and p53. One section from each positive control was used as negative control, by omitting the primary antibody. The slides were then washed with TBS twice for 5 min each. The Horse Radish Peroxidase (HRP) labeled polymer antimouse antibody (Biogenex) was incubated at room temperature. The slides were then washed in TBS and were incubated with fresh Diamino Benzidine (DAB) chromogen for 1-2 min. The slides were then washed with water and counter stained with Harris hematoxylin for 1 min. the slides were dehydrated through graded alcohol, cleared and mounted with Dibutyl Pthalate Xylene (DPX).
In order to evaluate the stained sections descriptively with Ki-67 and p53 antibodies, the numbers of positive cells in basal and parabasal regions in the lining epithelium of KCOTs were counted. Cell nuclei with bright brown color, regardless of the color intensity, were considered as positive cells for Ki-67 and p53. Cell counts were made at x400 magnification with conventional light microscope in ten randomly selected fields, counting minimum of 1,000 cells. Ki-67 and p53 LI were calculated.
Labeling Index (LI) = Number of IHC positive cells × 100 / Total number of cells observed.
Ki-67 and p53 LI were compared between the three groups (Solitary Sporadic vs. Recurrent), (Recurrent vs. Syndrome) and (Solitary Sporadic vs. Syndrome).
The Statistical software namely Minitab v14 was used for the analysis. Z test with predetermined alpha set at 0.05 (i.e. 5% - alpha is "level of significance") was used for the comparison of Ki-67 positivity between the three groups and p53 positivity between the three groups.
| Results and observation|| |
Anti-Ki-67 antigen antibodies reacted with nuclei in the cells of basal and parabasal layers of the lining epithelium of KCOTs [Figure 1], [Figure 2], [Figure 3]. Ki-67 LI were 30% in solitary sporadic, 26% in recurrent and 32% in syndrome-associated KCOTs which is slightly higher than the expression seen in solitary sporadic and recurrent cases [Table 1]. There was no statistical difference in the expression of Ki-67 between the three groups. Likewise, the expression of p53 was seen in the nuclei of basal and parabasal layers of epithelium [Figure 4], [Figure 5], [Figure 6]. p53 LI were 19% in solitary sporadic KCOTs, 23% in recurrent KCOTs and 21% in KCOTs-associated with syndrome, showing statistically no difference in the expression of p53 between the three groups [Table 2]. In all the cases, Ki-67 and p53 expression was more in the parabasal layers as compared to the basal layers.
|Figure 1: Ki-67 expression in basal and parabasal layer of solitary Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
|Figure 2: Ki-67 expression in in basal and parabasal layer of recurrent Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
|Figure 3: Ki-67 expression in in basal and parabasal layer of syndrome associated Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
|Figure 4: p53 expression in basal and parabasal layer in solitary Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
|Figure 5: p53 expression in basal and parabasal layer of recurrent Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
|Figure 6: p53 expression in in basal and parabasal layer of syndrome associated Keratocystic odontogenic tumor (IHC,×400)|
Click here to view
| Discussion|| |
KCOT is a unique lesion in the spectrum of odontogenic cysts and tumors. Besides the clinically and radiographically aggressive features, the inherent growth potential of its epithelium, its high recurrence rate (2.5-62.5%),  close relationship to the NBCCS and the alleged increased risk of neoplastic transformation have ensured that it remains extensively investigated for various aspects of its behavior. Although it is a well-known fact that behavioral differences exist between solitary, syndrome and recurrent KCOTs, the reasons for such differences are not well understood.
Some proliferation markers , and apoptotic proteins have been investigated to assess their role in such behavioral differences but with conflicting results. ,, In this research, we studied the expression of established markers like Ki-67 and p53 in solitary, syndrome and recurrent KCOTs.
Studies in the past have shown Ki-67 and p53 expression to be higher in the epithelium of KCOTs when compared with developmental and inflammatory cysts. Most of the Ki-67+ cells in KCOTs have been detected in the supra basal layers, suggesting high proliferative activity in these layers. , Similar pattern of staining has been noted for p53 too with its expression seen in the same areas where there is increased expression of Ki-67. ,,, The reason for this pattern is because p53 over-expression may promote cell proliferation in odontogenic lesions.
Our results also showed higher parabasal staining of Ki-67 and p53 in all the types of KCOTs but there was no statistically significant difference seen in the three study groups [Table 2], [Table 3], [Table 4]. Similar findings have been seen in other studies too. ,,,, However, contradictory results have been seen in few other publications where significant difference was seen in the expression of Ki-67 and p53 in syndrome cases compared to solitary or recurrent KCOTs. ,, Majority of them have attributed this to a genetic basis in KCOTs associated with syndrome. ,, Also, the lack of difference in expression seen between solitary and recurrent KCOTs has been credited to the fact that recurrences are mainly due to the treatment modality used and not because of any inherent behavioral differences. 
Overall, when the labeling indices were compared across the three groups it was seen that, as the expression of Ki-67 increased the expression of p53 decreased. Though this was not statistically significant, there was a trend seen in this direction [Table 1]. This indicates that there probably was a loss of balance between proliferation and apoptosis though not translating into any behavioral differences in the three groups.
|Table 1: Comparison of Ki‑67 and p53 expression between solitary, recurrent and syndrome‑associated KCOTs|
Click here to view
|Table 2: Comparision of Ki‑67 and p53 expression in basal and parabasal cells in solitary, recurrent and syndrome‑associated KCOT's|
Click here to view
|Table 3: Comparison of ki‑67 and p53 expression between different types of KCOT in basal layer|
Click here to view
|Table 4: Comparison of ki‑67 and p53 expression between different types of KCOT in parabasal layer|
Click here to view
Thus, from our study, we found that the rate of proliferation and apoptosis-related proteins in the epithelium may not be the only factors responsible for the variations seen in the biologic behavior of solitary, syndrome associated and recurrent KCOTs. In addition to epithelial factors, there may be mesenchymal factors or any unknown epithelial mesenchymal interactions which possibly could explain the variations in the aggressiveness of different types of KCOTs.
| Conclusion|| |
In conclusion, our study showed no difference in the rate of proliferation in the epithelial linings between the three groups. In cases, where Ki-67 positivity was high, there was reduced expression of p53, reflecting the loss of balance between the proliferative potential and apoptotic activity. On the basis of proliferative index alone, it is not possible to comment on biological behavior of KCOTs associated with syndrome versus those of Solitary Sporadic and Recurrent. Rate of recurrence and rate of growth are factors not solely dependent on epithelial proliferation but is probably multifactorial with a mesenchymal role as well, which needs to be researched. This also raises the clinical question whether on the basis of proliferative index alone these commonly occurring lesions of the jaws should be categorized as a benign neoplasm.
| References|| |
|1.||Philipsen HP. Keratocystic odontogenic tumor. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Head and Neck Tumours, WHO Classification of Tumours. Lyon: IARC Press; 2005. 1 (1) 306-7 |
|2.||Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 1999;78:1345-53. |
|3.||Ogden GR, Chisholm DM, Kiddie RA, Lane DP. p53 protein in odontogenic cysts: Increased expression in some odontogenic keratocysts. J Clin Pathol 1992;45:1007-10. |
|4.||Li TJ, Browne RM, Matthews JB. Epithelial cell proliferation in the odontogenic keratocysts. A comparative immunocytochemical study of Ki-67 in simple, recurrent and basal cell naevus syndrome (BCNS) associated lesions. J Oral Pathol Med 1995;24:221-6. |
|5.||Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol 1996;25:249-55. |
|6.||Myoung H, Hong SP, Hong SD, Lee J, Lim CY, Choung PH, et al. Odontogenickeratocyst: Review of 256 cases for recurrence and clinicopathologic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:328-33. |
|7.||Selvi F, Tekkesin MS, Cakarer S, Isler SC, Keskin C. Keratocystic odontogenic tumors: Predictive factors of recurrence by Ki-67 and AgNOR labelling. Int J Med Sci 2012;9:262-8. |
|8.||Mendes RA, Carvalho JF, Isaac VW. A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:333-9. |
|9.||Kimi K, Kumamoto H, Ooya K, Motegi K. Analysis of apoptotic related factors and apoptotic cells in lining epithelium of odontogenic keratocysts. Oral Med Pathol 2000;5:35-40. |
|10.||Kolar Z, Geierova M, Bouchal J, Pazdera J, Zboril V, Tvrdy P. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med 2006;35:75-80. |
|11.||Gadbail AR, Chaudhary M, Patil S, Gawande M. Actual proliferating index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis 2009;15:490-8. |
|12.||Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions: An immunohistochemical study. J Oral Pathol Med 1995;24:393-7. |
|13.||Gurgel CA, Ramos EA, Azevedo RA, Sarmento VA, da Silva Carvalho AM, Dos Santos JN. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: An immunohistochemical study. J Mol Histol 2008;39:311-6. |
|14.||Lombardi T, Odell EW, Morgan PR. p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal cell budding and basal-cell naevus syndrome. Arch Oral Biol 1995;40:1081-4. |
|15.||González-Moles MA, Mosqueda-Taylor A, Delgado-Rodríguez M, Martínez-Mata G, Gil-Montoya JA, Díaz-Franco MA, et al. Analysis of p53 protein by PAb240, Ki-67 expression and human papillomavirus DNA detection in different types of odontogenic keratocyst. Anticancer Res 2006;26:175-81. |
|16.||Jankowski Mac Donald DS, Li TK. Keratocystic odontogenic tumour in a Hong Kong community: The clinical and radiological features. Dentomaxillofac Radiol 2010;39:167-75. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
[Table 1], [Table 2], [Table 3], [Table 4]